MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1155/2013/560632

Медицинская библиотека · Mediators of inflammation · 2013

Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.

García-De-Vicuña Carmen, Díaz-Llopis Manuel, Salom David, Bou Rosa, Díaz-Cascajosa Jesus, Cordero-Coma Miguel, Ortega Gabriela, Ortego-Centeno Norberto, Suarez-De-Figueroa Marta, Cruz-Martínez Juan, Fonollosa Alex, Blanco Ricardo, García-Aparicio Ángel María, Benítez-Del-Castillo Jose M, Antón Jordi

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

PURPOSE: To assess the efficacy and safety of adalimumab in patients with juvenile idiopathic arthritis (JIA) and associated refractory uveitis.

DESIGN

Multicenter, prospective case series.

METHODS

Thirty-nine patients (mean [SD] age of 11.5 [7.9] years) with JIA-associated uveitis who were either not responsive to standard immunosuppressive therapy or intolerant to it were enrolled. Patients aged 13-17 years were treated with 40 mg of adalimumab every other week for 6 months and those aged 4-12 years received 24 mg/m(2) body surface.

RESULTS

Inflammation of the anterior chamber (2.02 [1.16] versus 0.42 [0.62]) and of the posterior segment (2.38 [2.97] versus 0.35 [0.71] decreased significantly between baseline and the final visit (P < 0.001). The mean (SD) macular thickness at baseline was 304.54 (125.03)  μ and at the end of follow-up was 230.87 (31.12)  μ (P < 0.014). Baseline immunosuppression load was 8.10 (3.99) as compared with 5.08 (3.76) at the final visit (P < 0.001). The mean dose of corticosteroids also decreased from 0.25 (0.43) to 0 (0.02) mg (P < 0.001). No significant side effects requiring discontinuation of therapy were observed.

CONCLUSION

Adalimumab seems to be an effective and safe treatment for JIA-associated refractory uveitis and may reduce steroid requirement.

Для цитирования: García-De-Vicuña Carmen, Díaz-Llopis Manuel, Salom David, Bou Rosa, Díaz-Cascajosa Jesus, Cordero-Coma Miguel, Ortega Gabriela, Ortego-Centeno Norberto, Suarez-De-Figueroa Marta, Cruz-Martínez Juan, Fonollosa Alex, Blanco Ricardo, García-Aparicio Ángel María, Benítez-Del-Castillo Jose M, Antón Jordi. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.. Mediators of inflammation. 2013. DOI: 10.1155/2013/560632.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.